Cited by 285Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis

Wahl, DG, Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., Thibaut, G.·1997·Lupus

DOI 10.1177/096120339700600510

Open this paper in CoChat — free account

Abstract

Objective: To describe the relative risk for venous thrombosis (VT) associated with antiphos pholipid antibodies (aPL) in systemic lupus erythematosus (SLE). Design: Systematic review and meta-analysis of 26 articles that examined the association between aPL and VT in SLE. Setting: Mostly secondary and tertiary referral centres. Patients: 2249 patients with SLE, 1120 tested for LA (lupus anticoagulant) and 1563 tested for aCL (anticardiolipin antibodies). Main outcome measures: A summary of study characteristics and a critical appraisal of study quality were done. Two statistical combinations of 18 primary studies that examined the association of VT and LA and of 14 studies that examined the association of VT and aCL were performed to estimate the risk for VT associated with aPL. Results: The odds ratios of the risk of VT related to the LA summarized from 18 studies were 5.61 [95% CI; 3.80-8.27] overall, 6.32 [CI; 3.71-10.78] for deep venous thrombosis and pulmonary embolism, 11.6 [3.65--36.91] for recurrent venous thrombosis after the first event. The odds ratios of the risk of VT related to aCL summarized from 14 studies were 2.17 [95% CI; 1.51-3.11] overall, 2.50 [CI; 1.51-4.14] for deep venous thrombosis and pulmonary embolism, 3.91 [1.14- 13.38] for recurrent venous thrombosis after the first event. Conclusions: Patients with SLE and LA are at approximately six times greater risk for VT than patients without LA, whereas patients with SLE and aCL are approximately two times greater risk for VT than patients without aCL. We have identified important methodologic limitations and differences in study characteristics. Other risk factors for VT have not been thoroughly evaluated in these studies. Further studies are needed that provide an accurate estimate of the absolute risk for aPL related VT.

Integrity signals

Registry

Crossref · 10.1177/096120339700600510

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 5,383
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents
Cook, D. J., Guyatt, G. H., Laupacis, A., Sackett, D. L., & Goldberg, R. J. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.227s · Cited by 275
Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus
Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246
Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
Anglés‐Cano, E., Sultan, Y., & Clauvel, J. (1979) · PubMed · Cited by 219
Thrombosis in Systemic Lupus Erythematosus
Glueck, H. I. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360080059007 · Cited by 192
Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus
KALUNIAN, K. C., Middlekauff, H. R., Sayre, J. A., Ando, D. G., Mangotich, M., Hahn, B. H., & Peter, J. B. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80229-8 · Cited by 150
Anticardiolipin antibodies in patients with systemic lupus erythematosus
Sturfelt, G. K., Nived, O., Norberg, R., Thorstensson, R., & Krook, K. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300404 · Cited by 124
SLE: a Rheumatological View. Analysis of the Clinical Features, Serology and Immunogenetics of 100 SLE Patients During Long-term Follow-up
Worrall, J. G., SNAITH, M. L., Batchelor, J. R., et al. (1990) · QJM · doi:10.1093/oxfordjournals.qjmed.a068440 · Cited by 114
Platelet Function and Coagulation Profile in Lupus Erythematosus
Regan, M. G., LACKNER, H., & KARPATKIN, S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-462 · Cited by 109

Show all 29 references

Research works printed but not linked: 9

Chalmers I, 1995, Systematic Reviews
Bowie Ejw, 1963, Clin Med, 62, 416
Angles-Cano E., 1979, J Lab Clin Med, 94, 312
Gladman DD, 1983, Q J Med, 52, 424
Petri M., 1987, Arch Intern Med, 106, 524
Rowell NR, 1989, Acta Derm Venereol (Stockh), 69, 111
Worrall JG, 1990, Q J Med, 74, 319
Wong KL, 1991, J Rheumatol, 18, 1187
Metz D., 1994, Presse Med, 23, 1797

Sorted by citations

Items 201–282 of 282

Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
Al-Jedai, A. H., Almudaiheem, H., Al-Homood, I. A., AlMaghlouth, I. A., Bahlas, S. M., Alolaiwi, A. M., Fatani, M. I. A., Eshmawi, M. T., Al-Omari, B. A., Alenzi, K. A. O., et al. (2024) · Current Rheumatology Reviews · doi:10.2174/0115733971275638240429063041 · Cited by 3
Viewpoint: Provoked thrombosis in antiphospholipid syndrome
Wahl, D. G., & Pengo, V. (2024) · Rheumatology · doi:10.1093/rheumatology/kead675 · Cited by 3
Self-citation
Definition and Epidemiology of Antiphospholipid Syndrome
Ünlü, O., Domingues, V., de Jesús, G. R., Zuily, S., Espinosa, G., Cervera, R., Levy, R. A., Wahl, D. G., Erkan, D., & Lockshin, M. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_7 · Cited by 4
Self-citation
Hematologic Manifestations of Childhood Illness
Ritchey, A. K., O’Brien, S. H., & Keller, F. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00152-9 · Cited by 3
Thromboembolic Disorders in Pregnancy
Pettker, C. M., & Lockwood, C. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00045-7 · Cited by 3
Short and long-term maternal outcomes in patients with phospholipid antibodies
Parke, A. L. (2004) · Lupus · doi:10.1191/0961203304lu2005oa · Cited by 3
Treatment of Antiphospholipid Antibody Syndrome
Wahl, D. G., & Regnault, V. (2006) · JAMA · doi:10.1001/jama.296.1.42 · Cited by 4
Self-citation
Evaluation of the Different Antiphospholipid Antibodies for the Diagnosis of Antiphospholipid Syndrome
Kaushik, P., MALAVIYA, A. N., Al-Attiya, R., Moussa, M. A. A., & Das, K. C. (1999) · Medical Principles and Practice · doi:10.1159/000026110 · Cited by 3
The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome
Alba, P. B., Bertolaccini, M. L., & Khamashta, M. A. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.613 · Cited by 3
Clinical Management of Antiphospholipid Syndrome-Related Thrombosis
Espinosa, G., & Cervera, R. (2010) · The Open Autoimmunity Journal · Cited by 3
“Antiphospholipids”: the more, the worse?
Wahl, D. G. (2018) · Blood · doi:10.1182/blood-2018-03-837831 · Cited by 3
Self-citation
Secondary Antiphospholipid Syndrome
Rahman, A., & Raimondo, M. G. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_19 · Cited by 3
β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies
de Groot, P. G., Bouma, B., Lutters, B. C. H., & Derksen, R. H. W. M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50007-3 · Cited by 3
The clinical significance of antiphospholipid antibodies in patients without autoimmune disease
Brighton, T., & Chesterman, C. N. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04364.x · Cited by 3
Inherited and Acquired Thrombophilia in Obstetrics
Paidas, M. J., Han, C. S., Hossain, N., & Lockwood, C. J. (2011) · Wiley-Blackwell eBooks · doi:10.1002/9781444328332.ch5 · Cited by 2
Schwere, nicht-infekti�se Mitralklappenendokarditis nach Klappenrekonstruktion bei einer 32-j�hrigen Patientin mit prim�rem Antiphospholipid-Syndrom
Herrmann, M., Key�er, G., Seige, M., et al. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0085-1 · Cited by 2
Pulmonary Manifestations of Systemic Lupus Erythematosus (SLE)
Mittoo, S., & Swigris, J. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0770-0_6 · Cited by 3
Antiphospholipid antibody syndrome—an overview
Sridevi, C., & Raju, P. K. (2011) · Journal of Indian College of Cardiology · doi:10.1016/s1561-8811(11)80022-2 · Cited by 2
Risk for thrombosis linked to the target antigen of a lupus anticoagulant?
Arnout, J. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00752.x · Cited by 2
Antiphospholipid Antibodies and Autoimmune Diseases
Remondino, G., & Allievi, A. (2010) · The Open Autoimmunity Journal · Cited by 2
Diagnosis of antiphospholipid syndrome
Bertolaccini, M. L., & Khamashta, M. A. (2008) · Expert Review of Hematology · doi:10.1586/17474086.1.2.183 · Cited by 2
[Contraconception in women with systemic lupus erythematosus].
Cravioto, M. D. C., Durand-Carbajal, M., & Sánchez‐Guerrero, J. (2009) · PubMed · Cited by 2
The Scientific Basis for Evaluation and Management of Thrombotic Disorders
Olcese, V. A., Stirling, M. J., & Lawson, J. H. (2006) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2006.07.003 · Cited by 2
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Abdelwahab, M., Kiefer, M. K., & Costantine, M. M. (2024) · Wiley eBooks · doi:10.1002/9781119820260.ch50 · Cited by 2
Management of Thrombosis in the Antiphospholipid Syndrome
Derksen, R. H. W. M., de Groot, P. G., & Brey, R. L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50034-6 · Cited by 2
Acquired platelet disorders
Altahan, R. M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1638994 · Cited by 1
Update Angiologie
Ranke, C., & Trappe, H. (1999) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03045049 · Cited by 1
Lung Disease in Systemic Lupus Erythematosus, Myositis, Sjögren’s Disease, and Mixed Connective Tissue Disease
Ghanem, M., Vasarmidi, E., Morer, L., Guen, P. L., & Crestani, B. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_14 · Cited by 1
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus
Penglong, T., Boontanvansom, A., Viboonjuntra, P., et al. (2023) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001247 · Cited by 1
Mesenteric venous thrombosis in a patient with antiphospholipid syndrome and systemic lupus erythematosus
Yong, Z., Wang, L., Chen, J., et al. (2013) · Asian Biomedicine · doi:10.5372/1905-7415.0705.231 · Cited by 1
“Results of a metaanalysis [5] found that the odds ratios of the risk of VT related to LA summarized from 18 studies were 5.”
Anticardiolipin and anti-ß2-glycoprotein 1 in Omani patients with anti-phospholipid syndrome
Alnaqdy, A., & Al-Shukaili, A. K. (2005) · Cited by 1
Pulmonary Manifestations of Connective Tissue Diseases
Hseun, T.-W., & Wu, R.-G. (2015) · 內科學誌 · doi:10.6314/jimt.2015.26(4).01 · Cited by 1
Diagnostic biologique du syndrome des antiphospholipides
Desage, S., & Dargaud, Y. G. (2020) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(20)30096-4 · Cited by 1
Inflammatory rheumatic diseases and pregnancy
Klimaszyk, K., Wender-Ożegowska, E., & Kędzia, M. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0152 · Cited by 1
Thromboembolic Disorders
Pettker, C. M., & Lockwood, C. J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06930-7.50043-8 · Cited by 1
Digital ulcers as presenting symptom of secondary antiphospholipid syndrome
Cravero, K., Maddy, A. J., & Motaparthi, K. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.08.042 · Cited by 2
ENHANCING DIAGNOSIS AND MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Danchenko, N. (2005) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Prognosis of Economy Class Syndrome Treated in Intensive Care Unit.
Hata, N., Tanaka, K., Imaizumi, T., et al. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.91 · Cited by 1
Thrombotic Vascular Disease
Moll, S., & White, G. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_27 · Cited by 1
The lung in systemic lupus erythematosus
Forbess, L. J., Wallace, D. J., Moore, R., & Jefferies, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00045-3 · Cited by 1
Immunologische Erkrankungen
Schaefer‐Prokop, C. M. (2003) · Thorax · doi:10.1007/978-3-642-55830-6_10 · Cited by 1
Assessment of ovarian reserve by biomarkers in female patients with primary APS, SLE-associated APS and SLEPreprint
Xu, X., Wang, H., & Wu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2839382/v1 · Cited by 1
Pathogenesis of antiphospholipid antibody syndrome
Tohidi‐Esfahani, I., Cohen, H., Ioannou, Y., & Giles, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00037-x · Cited by 1
Serological Biomarkers in Systemic Lupus Erythematosus
Chan, M. T.-L. (2013) · The University of Bath Online Publications Store (The University of Bath)
Thrombophilies Acquises
vasculaire, S. F. D. M., vasculaire, C. D. E. D. M., & vasculaire, C. F. D. P. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-71346-0.50016-1
The antiphospholipid syndrome.
Wautrecht, J. C. (2002) · PubMed
Anticoncepción en mujeres con lupus eritematoso sistémico
Naranjo, L. A. G., Duque, G. M. V., & Escobar, M. R. (2013) · IATREIA · doi:10.17533/udea.iatreia.14380
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Porter, T. F., & Branch, D. W. (2010) · Wiley eBooks · doi:10.1002/9781444316780.ch36
Atteintes pleuro-pulmonaires associées au lupus érythémateux
Borie, R., & Crestani, B. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71447-4.50035-0
Role of anti-prothrombin in antiphospholipid syndrome
Cinquini, M., Vianelli, M., Allegri, F., Cattaneo, R., Balestrieri, G., & Tincani, A. (2011) · Reumatismo · doi:10.4081/reumatismo.2002.243
Anticoncepción hormonal en mujeres jóvenes con enfermedades reumatológicas
Danisa Ivanovic-Zuvic, S., Carolina Pastene, S., Marcela Menéndez, A., et al. (2014) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262014000600002
Thrombophilie et syndrome des antiphospholipides
Meyer, G., & Lecompte, T. (2009) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(09)72484-x
Self-citation
Syndrome des antiphospholipides: diagnostic biologique et physiopathologie
Darnige, L. (2006) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(06)80046-8
On Diagnostic Procedures in Pulmonary Embolism
Söderberg, M. (2008) · Figshare
The antiphospholipid syndrome.
Grover, R., & Kumar, A. (2004) · PubMed
Clinical Studies Examining Thrombosis Related to Autoimmune Antiphospholipid Antibodies
Bertolaccini, M. L., & Khamashta, M. A. (2010) · The Open Autoimmunity Journal
T HE A NTIPHOSPHOLIPID S YNDROME
Evine, S. L., Are, D. W., Ranch, B., & Auch, J. O. R. (2002)
Acute Deep Venous Thrombosis
Vandy, F. C., & Wakefield, T. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00048-2 · Cited by 1
The Lung in Systemic Lupus Erythematosus
Chartrand, S., Fischer, A., & du Bois, R. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00043-7
Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome
Amengual, O., Bertolaccini, M. L., & Atsumi, T. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00004-1
Gynecologic Care and Contraception in the Medically Complex Adolescent
Jacobs, A. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66978-6_22
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Saoud, F., & Costantine, M. M. (2018) · Wiley eBooks · doi:10.1002/9781119129400.ch51
Inherited and Acquired Thrombophilias
Paidas, M. J. (2007) · Wiley eBooks · doi:10.1002/9780470691878.ch15
Epidemiology of venous thromboembolism with focus on risk markers
Johansson, M. (2019) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Thromboembolic Disorders of Pregnancy
Paidas, M. J., Pettker, C. M., & Lockwood, C. J. (2007) · Wiley eBooks · doi:10.1002/9780470753293.ch47
Lung
Fischer, A., & du Bois, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10045-2
Laboratory Testing for the Antiphospholipid Syndrome
Ahluwalia, J., & Sharma, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-0114-2_5
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
Root, P., & Isman, T. L. (2005)
Manifestaciones torácicas y dermatológicas de las enfermedades sistémicas: claves para el radiólogo general
Jaramillo, F. A., & Carvajal, J. E. M. (2020) · Revista colombiana de radiología · doi:10.53903/01212095.4
Inherited and Acquired Thrombophilias
Paidas, M. J. (2012) · Wiley eBooks · doi:10.1002/9781119963783.ch15
Lupus anticoagulant
Arnoux, D. (2006) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(06)76165-9
Systemic Lupus Erythematosus
Quigley, M., & Hansell, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-4048-4.50051-9
Clotting Disorders
Han, C. S., Paidas, M. J., & Lockwood, C. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5908-0.00041-7 · Cited by 1
Long-term Prognosis of Vascular Access in Haemodialysis Patients with Systemic Lupus Erythematosus: A Retrospective Cohort StudyPreprint
Chen, F.-Y., Chen, C.-F., Tan, A. C., Chan, C. C., Chen, F., Liu, W., Chen, T., Ou, S., Li, S., Tsai, M., et al. (2020) · doi:10.21203/rs.3.rs-111149/v1
Multidisciplinary approach in the management of pregnancy and rheumatic diseases – the challenges for obstetricians and gynecologists
Popovski, N. K., Николов, А., & Тотев, Т. (2022) · Rheumatology (Bulgaria) · doi:10.35465/30.3.2022.pp33-43
Impact of therapeutic and prophylactic anticoagulation after soft tissue tumor resection and microsurgical defect coverage in patients with high-risk coagulopathies or vascular diseasesPreprint
Daniel, B. W., Thielmann, J., Dragu, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2751836/v1
Laboratory Profile of Lupus Anticoagulant Positive Cases and its Association with Clinical Presentation- Experience from a Tertiary Care Centre in Southern India
Raghuram, P., Sekar, M. D., Srinivasan, L., Manivannan, P., Basu, D., & Kar, R. (2024) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-024-01851-6 · Cited by 1
10.1016/b978-0-323-39242-6.00004-x
(2000) · Time to knit · doi:10.1016/b978-0-323-39242-6.00004-x
Accelerated Atherogenesis and Antiphospholipid Antibodies
Matsuura, E., Kobayashi, K., & Lopez, L. R. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_40
“Antiphospholipid antibodies increase the risk of thrombosis by at least 2-fold when present in the context of an autoimmune disease [96].”
Background
Gradient of brain perfusion variation predicts thrombosis risk for patients with systemic lupus erythematosusPreprint
Wang, N., Cao, Z., Xu, R., Shang, S., Zhang, H., & Jia, J. (2026) · Research Square · doi:10.21203/rs.3.rs-8393739/v1
Venous Thromboembolic Disease
Krebs, J. R., Wakefield, T., & Jacobs, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-28432-8.00048-x
Atherogenesis and atherosclerosis in primary antiphospholipid syndrome
Ames, P. R. J. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Authors: Wahl, D., Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., & Thibaut, G.
Affiliations: Service de Medicine H., Nancy University Hospital, Nancy, France
Université de Lorraine (FR)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
ORCID: Guillemin, F.
de Maistre, E.
Lecompte, T.
Venue: Lupus
Publisher: SAGE Publications
Published: 1997-06
Volume: 6
Issue: 5
Pages: 467-473
ISSN: 0961-2033 (ISSN-L)
1477-0962
DOI: 10.1177/096120339700600510
OpenAlex: W2080975717
Semantic Scholar: c31dc580c59a1ad743aa46934306445622100694
Cited by: 285
References: 29
Citations by year: 2026: 3 · 2025: 3 · 2024: 11 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 9 · 2018: 4 · 2017: 10 · 2016: 11 · 2015: 7 · 2014: 5 · 2013: 11 · 2012: 5
FWCI: 1.89
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Lupus (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: venous thrombosis, antiphospholipid antibodies, systemic lupus erythematosus, lupus anticoagulant, anticardiolipin antibodies, deep vein thrombosis, pulmonary embolism, recurrent venous thrombosis, thrombosis risk
MeSH terms: Autoimmune Diseases, Disease Susceptibility, Epidemiologic Methods, Humans, Lupus Erythematosus, Systemic, Risk, Thrombophlebitis, Comorbidity, Odds Ratio, Single-Blind Method, Lupus Coagulation Inhibitor, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks